PKLR anticorps (N-Term)
Aperçu rapide pour PKLR anticorps (N-Term) (ABIN629803)
Antigène
Voir toutes PKLR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PKLR antibody was raised against the N terminal of PKLR
-
Purification
- Purified
-
Immunogène
- PKLR antibody was raised using the N terminal of PKLR corresponding to a region with amino acids STSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVRE
-
-
-
-
Indications d'application
-
WB: 5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PKLR Blocking Peptide, (ABIN5615398), is also available for use as a blocking control in assays to test for specificity of this PKLR antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PKLR antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PKLR (Pyruvate Kinase, Liver and RBC (PKLR))
-
Autre désignation
- PKLR
-
Sujet
- PKLR is a pyruvate kinase that catalyzes the production of phohsphoenolpyruvate from pyruvate and ATP. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA).
-
Poids moléculaire
- 58 kDa (MW of target protein)
-
Pathways
- Ribonucleoside Biosynthetic Process
Antigène
-